FDA Supplement Registration Requirements for Amazon Sellers in 2026

Amazon's compliance enforcement has quietly become one of the most aggressive delisting mechanisms in the supplement category. In Q1 2026, brands without current FDA facility registrations or with lapsed NDI (New Dietary Ingredient) notifications are being flagged at an accelerating rate—not just by regulators, but by Amazon's own compliance algorithms. The result: ASINs suspended mid-campaign, inventory stranded in FBA, and cash flow crises that take 30–90 days to resolve.

This isn't a beginner's checklist. If you're running a 7-figure supplement brand on Amazon, you already know the basics. What you need is a precise, current map of where the regulatory landscape shifted in 2025–2026, what Amazon is now cross-referencing against FDA databases, and how to build a compliance infrastructure that doesn't require a crisis to trigger action.

What Changed: The 2025–2026 Regulatory Shift

The FDA's 2025 Dietary Supplement Modernization priorities—partially codified under the Dietary Supplement Listing Act framework that gained traction in late 2024—introduced three material changes that affect Amazon sellers directly:

1. Voluntary Product Listing (VPL) Pressure: While still technically voluntary, the FDA's Dietary Supplement Label Database (DSLD) submissions are now being used by Amazon's Brand Compliance team as a verification signal. Brands not listed face higher scrutiny thresholds.
2. Facility Registration Renewal Cycles: FDA facility registrations under 21 CFR Part 111 (cGMP) must be renewed every two years during the October–December window. Brands that missed the 2024 renewal window are operating with lapsed registrations in 2026—a direct ASIN suspension trigger.
3. NDI Notification Scrutiny: The FDA issued updated NDI guidance in mid-2025 clarifying that reformulations—including changes to delivery format (e.g., capsule to gummy), ingredient concentration changes above 15%, or new combination ingredients—require fresh NDI notifications. Many brands reformulated during the post-COVID supply chain disruption and never filed.

The Core Registration and Filing Matrix

Understanding which filings apply to your specific product profile is the first step to building a defensible compliance posture.

Operator Note: Amazon's Brand Compliance team now cross-references FDA facility registration numbers against the FDA's public database in near real-time. A lapsed registration that was tolerated in 2023 will trigger an automated flag in 2026. This is not hypothetical—it's happening to brands in the top 500 of the Sports Nutrition and Vitamins categories right now.

NDI Notifications: The Most Underestimated Risk

Of all the compliance obligations in the supplement space, NDI notifications carry the highest risk-to-awareness ratio. Here's the operational reality:

• ~80% of supplement ingredients introduced after 1994 technically require an NDI notification before marketing
• The FDA has received fewer than 1,500 NDI notifications total since the program's inception—a fraction of what should exist
• Amazon's legal team, responding to competitor IP complaints and regulatory pressure, has begun requesting NDI documentation as part of ASIN reinstatement appeals
• Preparation and submission of an NDI notification costs $15,000–$45,000 in legal and scientific fees; the cost of an ASIN suspension in a competitive supplement category averages $8,000–$22,000 per week in lost revenue

Triggering events that require a new or updated NDI notification:

• Changing the chemical form of an ingredient (e.g., magnesium oxide → magnesium glycinate)
• Increasing ingredient dosage beyond the range established in the original notification
• Combining two previously separate NDI-notified ingredients into a single product
• Switching from a synthetic to a whole-food-derived source of the same ingredient

Building a Compliance Infrastructure That Scales

Fragmented compliance management—a spreadsheet here, a law firm email thread there—breaks at scale. Brands operating 20+ active supplement ASINs across multiple Amazon marketplaces need a systematized approach.

The five operational layers of a defensible compliance stack:

1. Regulatory Calendar Automation: Every filing deadline, renewal window, and adverse event reporting clock should live in a system that sends escalating alerts—not in someone's inbox. Missed FDA facility renewals are almost always a calendar failure, not a knowledge failure.

2. Ingredient-Level Documentation Architecture: Each ingredient in your formulation library should have a dedicated compliance file: NDI status, GRAS determination (if applicable), supplier COAs, and safety data. When Amazon requests documentation, response time under 48 hours is the difference between a temporary hold and a full suspension.

3. Label Change Version Control: Every label revision—even a font change—should be logged with the reason, date, and compliance review sign-off. Amazon's brand registry cross-references label images, and discrepancies between your registered label and live listing images are a suspension vector.

4. Supplier Qualification Audits: Your cGMP compliance is only as strong as your contract manufacturer's. Annual supplier audits with documented corrective action plans are the standard for brands that survive FDA inspections.

5. Proactive DSLD Submissions: Submit to the FDA's Dietary Supplement Label Database before your product goes live on Amazon. This creates a public record that functions as a compliance signal to Amazon's algorithms and provides a defensible paper trail.

International Brands Entering the U.S. Market

For EU, UK, and Asian supplement brands entering Amazon US in 2026, the regulatory delta is significant. European compliance frameworks (Novel Food Regulation, EFSA standards) do not transfer to U.S. FDA requirements. Key gaps:

• EU Novel Food authorization ≠ FDA GRAS or NDI notification: A fully authorized EU Novel Food ingredient still requires independent NDI notification or GRAS determination for U.S. marketing
• U.S. facility registration is required for foreign manufacturers shipping to U.S. consumers, including FBA inventory
• Labeling format requirements differ substantially: U.S. Supplement Facts panels, serving size conventions, and structure/function claim rules are distinct from EU standards

Brands attempting to launch U.S. Amazon operations with EU-compliant labeling and no U.S. regulatory filings are building on a foundation that will collapse at the first compliance review.

Conclusion: Compliance as Competitive Infrastructure

In 2026, FDA compliance for supplement brands isn't a legal checkbox—it's an operational moat. Brands with clean, documented, audit-ready compliance infrastructure list faster, survive Amazon enforcement actions, and convert better (trust signals matter in a category where consumers are increasingly skeptical).

Immediate action items for Q2 2026:

• Audit your FDA facility registration status and confirm your 2024 renewal was processed
• Pull your full ingredient list and cross-reference against the FDA's NDI notification database
• Submit any unlisted products to the DSLD before your next product launch
• Implement a regulatory calendar with 90/60/30-day alerts for all renewal windows
• Brief your 3PL or FBA prep partner on documentation requirements for any new SKUs

The brands that treat compliance as infrastructure—not overhead—are the ones that compound. The ones that treat it as a fire to put out are the ones that get delisted during their peak season.